| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |